Ken Griffin Eyenovia, Inc. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$0.46 - $1.44 $9,062 - $28,368	-19,700 Reduced 60.06%	13,100 $6,000
Q2 2024 Aug 14, 2024	BUY	$0.52 - $1.06 $5,564 - $11,342	10,700 Added 48.42%	32,800 $19,000
Q1 2024 May 15, 2024	BUY	$0.99 - $2.37 $14,652 - $35,076	14,800 Added 202.74%	22,100 $21,000
Q4 2023 Feb 14, 2024	SELL	$1.08 - $2.08 $432 - $832	-400 Reduced 5.19%	7,300 $15,000
Q3 2023 Nov 14, 2023	BUY	$1.57 - $2.54 $11,932 - $19,304	7,600 Added 7600.0%	7,700 $12,000
Q2 2023 Aug 14, 2023	BUY	$2.21 - $5.75 $221 - $575	100 New	100 $0

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $2.74M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.